My business is in the regulated cannabis tech space. Who are the go-to VCs for this industry?

In the regulated cannabis tech space (B2B software, compliance, supply chain tracking, e-commerce, and ancillary services), fundraising requires targeting funds that explicitly understand the regulatory hurdles or have dedicated theses for the sector.

The go-to venture capital firms and institutional investors focusing on cannabis tech and ancillary services include:

• Casa Verde Capital — Co-founded by Snoop Dogg, this is arguably the premier name in cannabis VC. They focus heavily on seed and growth-stage ancillary businesses, including B2B tech, compliance, and supply chain solutions.
• Merida Capital Holdings — A private equity and venture capital firm targeting fundamental infrastructure, analytics, and tech-enabled services across the regulated cannabis ecosystem.
• Entourage Effect Capital — One of the more prolific institutional investors in the space, backing both plant-touching and high-growth ancillary/tech enterprises.
• Gotham Green Partners — A massive player providing growth capital across the entire value chain, frequently looking at tech, data platforms, and major operational infrastructure.
• Phyto Partners — Specifically focuses on early-stage companies operating in the cannabis ancillary space, with a strong appetite for cannabis-adjacent SaaS, B2B software, and tech platforms.
• Poseidon Asset Management — A long-standing investment firm in the sector that understands the multi-state operator (MSO) landscape and frequently backs tech solutions solving compliance and operational pain points.
• Draper B1 — Part of the broader Draper network, they invest in early-stage and seed B2B/B2B2C tech startups, occasionally dipping into regulated/ancillary tech sectors where legal frameworks permit.

Strategic Tip for Pitching Cannabis Tech

Because you are on the tech/ancillary side rather than plant-touching, emphasize your scalability, high gross margins, and how easily your product decouples from direct plant liability. Many traditional or generalist tech VCs are still gun-shy about anything touching THC, so leading with your B2B SaaS metrics, regulatory moat (e.g., METRC integrations, track-and-trace compliance), and enterprise value proposition will be your strongest angles. You can also explore curated matching platforms like OpenVC's Cannabis Investor Directory to filter active check-sizes and thesis fits.

Yes. If you’re regulated-cannabis tech rather than plant-touching, I’d prioritize investors who understand compliance, fragmented state markets, SaaS, payments, data, and infrastructure—not just cannabis consumer brands.

My go-to shortlist

A useful cross-check: current 2026 investor data puts Casa Verde, Poseidon and Phyto at the top of U.S. cannabis VC activity, with software/SaaS explicitly represented in their focus.

I'd actually run two fundraising tracks

Track 1 — Cannabis-native

Casa Verde → Poseidon → 7thirty → Phyto → Premo → Entourage Effect → Merida.

These investors understand the weirdness of the market: state-by-state regulation, 280E, banking limitations, Metrc integrations, fragmented operators, compliance burden, etc.

Track 2 — Mainstream technology investors

This is potentially more important depending on what you've built.

If you're selling compliance software, fintech/payments, identity/KYC, ERP, data, AI, supply-chain software, insurance/risk tech, lab infrastructure, or vertical SaaS, I'd pitch the company as:

“Enterprise software infrastructure for one of the world's most heavily regulated emerging markets.” rather than simply:

“Cannabis technology company.” That framing can dramatically expand the investor universe. There is already precedent for conventional technology investors backing cannabis infrastructure.

One investor I'd put unusually high on your list

7thirty Capital stands out because its stated thesis is almost a direct description of regulated cannabis infrastructure: software, compliance, data, supply chain, SaaS, marketplaces and deep tech, while explicitly avoiding direct cultivation/retail.

So if you're, say, B2B SaaS selling into licensed operators, I'd probably put 7thirty + Poseidon + Casa Verde + Premo at the top of the first outreach wave.

If you tell me (1) what your product does, (2) current ARR/revenue, (3) amount you're raising, (4) pre-seed/seed/A/etc., and (5) whether you touch the plant or money, I can turn this into a ranked 20–30 investor target list, including likely check size, stage, relevant portfolio companies, and which partner at each fund I'd approach.

The leading venture capital firms specializing in the regulated cannabis tech and ancillary space include Casa Verde Capital, Entourage Effect Capital , and Salveo Capital.

Because federal illegality restricts many traditional institutional tech VCs from backing plant-touching operators, specialized sector-focused firms concentrate heavily on non-plant-touching technology, compliance software, B2B marketplaces, supply chain tracking, and agtech.

Top Venture Capital Firms for Cannabis Tech

Key Strategic Tips for Pitching Cannabis Tech VCs

• Emphasize "Ancillary" Status: Clearly highlight how your software or hardware avoids direct plant-touching liabilities, which dramatically broadens your addressable investor pool.
• Lead with Compliance & Regulation: Regulatory tracking, security, and data verification tools are heavily prioritized by specialized cannabis VCs navigating multi-state operator (MSO) complexities.
• Target High-Net-Worth Syndicates: Alongside dedicated funds, a substantial portion of capital in this sector originates from specialized angel networks and family offices experienced in regulatory risk.

Yes. If you’re regulated cannabis tech rather than plant-touching, I’d prioritize investors who understand compliance-heavy SaaS, payments, data, POS/ERP, supply chain, and the state-by-state regulatory mess.

My short list

Current investor databases put Casa Verde, Poseidon and Phyto at the top of the cannabis/software intersection, with Poseidon specifically characterized around cannabis software/SaaS.

7thirty is especially interesting for a pure technology company. Its stated thesis is cannabis technology and cannabis-adjacent opportunities in regulated markets, including SaaS, med-tech, ag-tech, marketplaces and deep tech, while excluding direct cultivation.

arcviewgroup.com is also worth knowing because it operates as a broader cannabis ecosystem connecting entrepreneurs, investors and industry participants—not simply as a conventional VC fund.

The bigger opportunity: don't limit yourself to cannabis VCs

If your product is genuinely software infrastructure for a regulated industry, I'd run two fundraising tracks simultaneously:

• Cannabis-native: Casa Verde, Poseidon, Phyto, 7thirty, Merida, Entourage Effect.
• Generalist vertical SaaS / fintech / regtech: investors who care about the underlying technology and can eventually see cannabis as your beachhead rather than your entire TAM.

That's important because a company selling compliance automation, payments, KYC, inventory, ERP, POS, supply-chain software, testing infrastructure, insurance/risk or B2B data can have a much bigger investor universe than a company pitching itself simply as "cannabis tech."

There is precedent for mainstream tech investors backing cannabis infrastructure: YC, for example, has backed cannabis software businesses, while some vertical-SaaS investors have participated in cannabis compliance/marketing software.

If I were building your target list

I'd probably start with 15–25 names, rather than blast 200 cannabis funds, and rank them based on:

1. Your exact product category
2. Seed / A / B stage
3. Current ARR and growth rate
4. Whether you're plant-touching
5. Which states/countries you're operating in
6. Whether you're selling to operators, regulators, consumers, or other businesses
7. Your desired round size

If you tell me what the product does, current ARR/revenue, round you're raising, and whether you're plant-touching, I can turn this into a ranked investor target list with specific funds, relevant partners, check sizes, portfolio overlaps, and the best angle for approaching each one.

arcviewgroup.com is also worth knowing because it operates as a broader cannabis ecosystem connecting entrepreneurs, investors and industry participants—not simply as a conventional VC fund.

The bigger opportunity: don't limit yourself to cannabis VCs

If your product is genuinely software infrastructure for a regulated industry, I'd run two fundraising tracks simultaneously:

The go-to venture capital firm specializing explicitly in the cannabis ancillary and tech infrastructure space is Casa Verde Capital , alongside specialized networks and selective mainstream funds.

Because federal illegality prevents traditional institutional VCs from touching direct "plant-touching" operators, the sector relies heavily on ancillary-focused funds that back B2B software, compliance, logistics, and supply chain tech.

Dedicated Cannabis Tech VCs & Networks

• Casa Verde Capital : Co-founded by Snoop Dogg, this is the premier name in cannabis venture capital . They focus entirely on the ancillary layer—avoiding plant-touching risk—and have backed major tech infrastructure giants like Dutchie, LeafLink, and Vangst.
• The Arcview Group : Operates a massive investor network that has funneled hundreds of millions into early-stage cannabis enterprise, leaning heavily into data, compliance, and B2B tech services.
• Poseidon Asset Management : An experienced investment firm focusing across the cannabis value chain, selectively prioritizing ancillary business models with strong defensible technology.

Alternative Capital Sources for Cannabis Tech

• Family Offices & High-Net-Worth Syndicates : Due to ongoing federal restrictions, a vast percentage of early-to-growth rounds in cannabis tech are financed by specialized high-net-worth individual networks and private family offices rather than mainstream institutional multi-stage funds.
• Generalist B2B / SaaS VCs : If your technology is strictly enterprise software (e.g., seed-to-sale tracking, data analytics, age-verification, or HR compliance) and does not handle transactions or plant operations directly, select mainstream B2B SaaS or fintech micro-VCs will occasionally participate if the regulatory risk is walled off.

If you’re regulated cannabis tech / ancillary, rather than a cultivator, processor, or cannabis brand, I’d focus on investors who understand vertical SaaS, compliance, payments, data, supply chain, and cannabis-specific regulatory complexity.

The go-to cannabis-tech investors

A current investor database puts Casa Verde, Poseidon and Phyto at the top of U.S. cannabis VC activity, with software/SaaS explicitly represented in all three investment theses.

But I'd make one important distinction

Don't necessarily pitch yourself as a "cannabis startup."

If you're building, say, compliance automation, payments infrastructure, identity/KYC, ERP, supply-chain software, AI, data infrastructure, laboratory technology, insurance/risk tech, etc., your stronger story may be:

"We're a vertical technology company serving one of the world's most complex regulated markets." That's potentially a much larger investor universe.

There is precedent: Y Combinator currently lists cannabis companies including Canix (cannabis compliance/operations SaaS), Nabis (B2B wholesale/fintech/analytics), and Confident LIMS.

So I'd run two parallel fundraising tracks:

• Cannabis-native: Casa Verde, Poseidon, Phyto, 7thirty, Entourage Effect, Merida.
• Generalist vertical SaaS / fintech / regtech: investors whose thesis matches your technology, regardless of cannabis.

The second bucket can become especially important if you're building something that can eventually expand beyond cannabis into alcohol, pharma, psychedelics, tobacco, food, agriculture, or other regulated industries.

If you give me 4 things, I can make this much more actionable

1. What the product does (e.g. compliance, payments, POS, AI, supply chain)
2. Stage (pre-seed, seed, Series A, etc.)
3. Current ARR/revenue
4. Plant-touching or ancillary?

I can then give you a prioritized 15–20-investor target list, including likely check size, stage, relevant portfolio companies, and who at each fund I'd actually try to get an introduction to.

Don't necessarily pitch yourself as a "cannabis startup."

If you're building, say, compliance automation, payments infrastructure, identity/KYC, ERP, supply-chain software, AI, data infrastructure, laboratory technology, insurance/risk tech, etc., your stronger story may be:

"We're a vertical technology company serving one of the world's most complex regulated markets." That's potentially a much larger investor universe.

There is precedent: Y Combinator currently lists cannabis companies including Canix (cannabis compliance/operations SaaS), Nabis (B2B wholesale/fintech/analytics), and Confident LIMS.

So I'd run two parallel fundraising tracks:

Navigating venture capital in the regulated cannabis tech space requires targeting funds that specifically understand "ancillary" cannabis businesses—meaning software, compliance, supply chain, and B2B tech platforms that avoid direct plant-touching regulatory hurdles.

The premier venture capital firms and institutional investors actively tracking and deploying capital in the cannabis technology and ecosystem space include:

• Casa Verde Capital : Widely considered the premier go-to VC in the cannabis sector. Co-founded and backed by prominent cultural and business figures, this Los Angeles-based firm focuses heavily on seed and growth-stage ancillary businesses, including B2B software, compliance, ag-tech, and financial services. Their portfolio includes major tech/service players like Dutchie and Frontier Risk.
• Delta Emerald Ventures : A specialized venture capital fund focused on early-stage and Series A/B investments across cannabis tech, enterprise SaaS, and data analytics (such as Happy Cabbage Analytics). They act as an active, strategic partner for operational tech in the ecosystem.
• Phyto Partners : An active venture capital fund targeting early-stage (Seed and Series A) investments in ancillary cannabis businesses, tech platforms, and ad-tech/marketing solutions. They have a strong history of backing major foundational infrastructure in the space like LeafLink and Flowhub.
• Merida Capital Holdings : A hybrid private equity and venture capital firm that targets fundamental picks-and-shovels plays, data, security, and cultivation/extraction technology systems. They lean slightly towards growth equity but take early-stage tech bets.
• Entourage Effect Capital : Formerly Cresco Capital Partners, this prominent private equity and VC firm invests heavily across the supply chain, investing in cultivation infrastructure, distribution tech, and ancillary business services.
• Altitude Investment Management : A global venture capital fund investing across early-stage and growth-stage cannabis companies, emphasizing tech-enabled business services, B2B solutions, and med-tech.
• Gotham Green Partners : A large-scale private equity and venture firm deploying capital globally across the value chain, occasionally participating in larger technology and data platform rounds.

Strategic Tips for Pitching Cannabis Tech:

1. Emphasize "Ancillary" Status: Explicitly highlight how your software or hardware keeps operators compliant, reduces friction, or scales efficiency without handling the plant itself. This drastically broadens your appeal to institutional LPs who have strict mandates against plant-touching assets.
2. Lean on Unit Economics: Because generalist Silicon Valley VCs can still be squeamish regarding federal regulations, specialized cannabis tech VCs look heavily for predictable, high-retention SaaS metrics or high-margin B2B models.

For a regulated cannabis tech company (software, compliance, payments, data, ERP, marketplaces, logistics, retail enablement, AI, etc.), the best investors are usually cannabis-specialist funds plus a layer of vertical SaaS / fintech / RegTech investors. The specialists understand the regulatory friction and can help with industry relationships.

Here are the names that tend to come up most often:

A good fundraising strategy is usually:

If you are B2B SaaS / compliance / RegTech

Prioritize:

1. Casa Verde Capital
2. Poseidon Asset Management
3. Phyto Partners
4. Merida Capital Holdings
5. Generalist vertical SaaS funds that invest in regulated industries

If you are payments / banking / financial infrastructure

Add:

• FinTech VCs
• Banking infrastructure investors
• Compliance/KYC/AML investors

Cannabis payments is often viewed as a financial infrastructure problem, not just a cannabis problem.

If you are data / AI / analytics

Position it as:

• regulated-market intelligence
• enterprise data infrastructure
• compliance automation
• operational optimization

That framing can open doors to non-cannabis investors.

If I were building a first-pass target list

I’d probably start with:

1. Casa Verde Capital
2. Poseidon Asset Management
3. Phyto Partners
4. Entourage Effect Capital
5. Merida Capital Holdings
6. Achari Ventures
7. Arcview network
8. 5–10 vertical SaaS/RegTech funds that are comfortable with regulated markets

One important distinction: investors care a lot about whether you are plant-touching (holding licenses, handling product, operating facilities) versus ancillary tech (software/infrastructure). Ancillary companies generally have a much larger investor universe because many institutional VCs are willing to fund software serving cannabis without investing directly in cannabis operators.

If you share your product category, stage (pre-seed/seed/A), ARR or traction, and raise size, I can narrow this to a tighter list of likely-fit investors and partners.

Yes. If you're regulated cannabis tech rather than a cannabis cultivator/brand, I'd bias heavily toward investors that understand ancillary software, compliance, payments, data, and infrastructure.

My shortlist

Recent investor databases put Poseidon, Casa Verde and Phyto Partners among the most active cannabis VC funds, with particularly substantial software/SaaS exposure.

The important distinction for you

I'd actually build your fundraising list in two buckets:

1. Cannabis-native investors
Casa Verde, Poseidon, Phyto, 7thirty, Arcview, Entourage Effect, Merida.

These investors understand why selling software into a highly fragmented, state-by-state regulated market is difficult—and why that regulatory complexity can become a moat.

2. Generalist SaaS/fintech/regtech investors

This is potentially more important if your product is, for example:

• compliance automation
• payments/financial infrastructure
• identity/KYC
• inventory or supply-chain software
• ERP/POS
• B2B data
• AI/automation
• insurance/risk
• laboratory/testing infrastructure

There are examples of conventional software investors backing cannabis infrastructure: Act One Ventures, for example, focuses on compliance, vertical SaaS and fintech and has backed cannabis seed-to-sale software company BLAZE.

And the fact that Y Combinator has backed cannabis software companies such as Canix and Nabis is a useful signal that you don't necessarily need to pitch yourself as a "cannabis company" to mainstream tech investors.

If I were building your target list

I'd probably rank Casa Verde → Poseidon → Phyto → 7thirty → Arcview as the first five conversations, then supplement them with 10–20 generalist VCs whose thesis matches your actual technology.

The key question is what kind of regulated cannabis tech you're building. If you tell me (1) what the product does, (2) pre-seed/seed/A, (3) ARR/revenue and growth, and (4) plant-touching vs. ancillary, I can turn this into a ranked 20–30 investor target list, including likely check sizes, relevant portfolio companies, and which partners I'd approach at each fund.

Navigating the regulated cannabis tech space requires investors who not only understand software, B2B SaaS, or supply chain logistics, but also know how to manage the regulatory gray areas and risk profiles unique to the cannabis ecosystem.

The venture capital and institutional landscape for cannabis tech features dedicated vertical funds alongside generalist firms that cross over into ancillary tech.

Dedicated Cannabis-Focused VCs

These firms specialize entirely or primarily in the cannabis ecosystem, frequently backing B2B SaaS, compliance, cultivation tech, and marketplaces.

• Casa Verde Capital — Co-founded by Snoop Dogg, Casa Verde is arguably the most prominent name in ancillary cannabis investing. They focus on seed and growth-stage B2B infrastructure, logistics, and technology platforms that power the cannabis industry without touching the plant directly.
• Entourage Effect Capital — Formerly Cresco Capital Partners, this firm has deployed multiple dedicated funds into the legalized cannabis value chain, heavily prioritizing scalable ancillary services and tech-enabled operators.
• Phyto Partners — An early-stage VC fund that specifically targets cannabis and hemp-related B2B software, SaaS, compliance tools, and tech infrastructure (notable past early bets include companies like LeafLink and Flowhub).
• Altitude Investment Management — A global cannabis investment firm that actively participates in early-stage and growth rounds for tech, data analytics, and business services (B2B) in the space.
• Gotham Green Partners — A major private equity and venture firm focused on global cannabis and tech-enabled value chains, often stepping in for larger Series A/B+ rounds.

Mainstream & Crossover Tech VCs

If your tech stack leans heavily into enterprise SaaS, deep data, or AI-driven compliance, mainstream tech funds have a history of making high-conviction plays in top-tier cannabis technology (preferring software over plant-touching operations).

• Founders Fund — Known for contrarian, high-conviction bets, Peter Thiel’s firm has historically backed major players in the broader cannabis and regulatory tech infrastructure space.
• Thrive Capital — Josh Kushner’s fund has led major institutional rounds in dominant cannabis commerce and software ecosystems (such as Dutchie's major rounds).
• TVC Capital — A growth equity firm focused on mission-critical software and B2B vertical SaaS that has notably crossed over into scaling cannabis compliance and marketing software.

Accelerators & Early Micro-VCs

If you are at the pre-seed or seed stage, getting into a generalist tech accelerator with an open-door policy for regulated tech can open doors to institutional follow-on rounds.

• Y Combinator — Has backed multiple standout cannabis ERP and supply chain software startups (such as Canix) that went on to raise substantial institutional tech rounds.
• Poseidon Asset Management — One of the oldest continuously operating investment firms in the sector, specializing in strategic early-stage capital for tech and ancillary operators.